Bis-Arg-rhodamine 110

Ordering information

Price
Catalog Number
Unit Size
Quantity

Add to cart

Additional ordering information

Telephone	1-800-990-8053
Fax	1-800-609-2943
Email	sales@aatbio.com
International	See distributors
Bulk request	Inquire
Custom size	Inquire
Shipping	Standard overnight for United States, inquire for international

Request quotation

Physical properties

Molecular weight	1098.81
Solvent	DMSO

Spectral properties

Extinction coefficient (cm ^-1 M ^-1)	80000
Excitation (nm)	500
Emission (nm)	522

Storage, safety and handling

H-phrase	H303, H313, H333
Hazard symbol	XN
Intended use	Research Use Only (RUO)
R-phrase	R20, R21, R22
Storage	Freeze (< -15 °C); Minimize light exposure
UNSPSC	12352200

Overview SDS Protocol

Calculators

Common stock solution preparation

Table 1. Volume of DMSO needed to reconstitute specific mass of Bis-Arg-rhodamine 110 to given concentration. Note that volume is only for preparing stock solution. Refer to sample experimental protocol for appropriate experimental/physiological buffers.

	0.1 mg	0.5 mg	1 mg	5 mg	10 mg
1 mM	91.008 µL	455.038 µL	910.075 µL	4.55 mL	9.101 mL
5 mM	18.202 µL	91.008 µL	182.015 µL	910.075 µL	1.82 mL
10 mM	9.101 µL	45.504 µL	91.008 µL	455.038 µL	910.075 µL

Molarity calculator

Enter any two values (mass, volume, concentration) to calculate the third.

Mass (Calculate)		Molecular weight		Volume (Calculate)		Concentration (Calculate)		Moles
	/		=		x		=

Spectrum

Open in Advanced Spectrum Viewer

Spectral properties

Extinction coefficient (cm ^-1 M ^-1)	80000
Excitation (nm)	500
Emission (nm)	522

Images

Figure 1. Chemical structure for Bis-Arg-rhodamine 110.

Citations

View all 11 citations: Citation Explorer

NMR reveals a dynamic allosteric pathway in thrombin
Authors: H, undefined and ley, L. D., Fuglestad, B., Stearns, K., Tonelli, M., Fenwick, R. B., Markwick, P. R., Komives, E. A.
Journal: Sci Rep (2017): 39575

Continuous-flow injection microfluidic thrombin assays: The effect of binding kinetics on observed enzyme inhibition
Authors: Ramjee, M. K., Patel, S.
Journal: Anal Biochem (2017): 38-46

Inherited Anti-Thrombin Deficiency in A Malay-Malaysian Family: A Missense Mutation at Nucleotide g.13267C>A aka anti-thrombin Budapest 5 (p.Pro439Thr) of the SERPINC 1 gene
Authors: Norlelawati, A. T., Rusmawati, I., Naznin, M., Nur Nadia, O., Rizqan Aizzani, R., Noraziana, A. W.
Journal: Med J Malaysia (2014): 27-30

The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis
Authors: Mosnier, L. O., Meijers, J. C., Bouma, B. N.
Journal: Thromb Haemost (2001): 1040-6

Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation
Authors: Mosnier, L. O., Elisen, M. G., Bouma, B. N., Meijers, J. C.
Journal: Thromb Haemost (2001): 1057-64

Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA
Authors: Colucci, M., D'Aprile, A. M., Italia, A., Gresele, P., Morser, J., Semeraro, N.
Journal: Thromb Haemost (2001): 661-6

Synergistic actions of a thrombin-derived synthetic peptide and a thrombin receptor-activating peptide in stimulating fibroblast mitogenesis
Authors: Hollenberg, M. D., Mokashi, S., Leblond, L., DiMaio, J.
Journal: J Cell Physiol (1996): 491-6

Efficient production of the C-terminal domain of secretory leukoprotease inhibitor as a thrombin-cleavable fusion protein in Escherichia coli
Authors: Masuda, K., Kamimura, T., Kanesaki, M., Ishii, K., Imaizumi, A., Sugiyama, T., Suzuki, Y., Ohtsuka, E.
Journal: Protein Eng (1996): 101-6

Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C)
Authors: Naul, undefined and , U., Rijken, D. C.
Journal: Eur J Biochem (1994): 497-501

Amidinated thrombin: preparation and peptidase activity
Authors: Kang, E. P.
Journal: Thromb Res (1978): 177-80